Phase I study of SU011248 [sunitinib] in combination with oxaliplatin, leucovorin [folinic acid], and 5-fluorouracil [fluorouracil] in patients with advanced solid malignancies.

Trial Profile

Phase I study of SU011248 [sunitinib] in combination with oxaliplatin, leucovorin [folinic acid], and 5-fluorouracil [fluorouracil] in patients with advanced solid malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jul 2015

At a glance

  • Drugs Fluorouracil; Folinic acid; Oxaliplatin; Sunitinib
  • Indications Colorectal cancer; Solid tumours
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 17 Jul 2009 Actual number of patients (53) added as reported by ClinicalTrials.gov.
    • 01 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Jan 2009 Planned end date changed from 1 Oct 2008 to 1 Nov 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top